161 related articles for article (PubMed ID: 9748149)
1. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
Oda Y; Sakamoto A; Shinohara N; Ohga T; Uchiumi T; Kohno K; Tsuneyoshi M; Kuwano M; Iwamoto Y
Clin Cancer Res; 1998 Sep; 4(9):2273-7. PubMed ID: 9748149
[TBL] [Abstract][Full Text] [Related]
2. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
3. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer.
Shibahara K; Sugio K; Osaki T; Uchiumi T; Maehara Y; Kohno K; Yasumoto K; Sugimachi K; Kuwano M
Clin Cancer Res; 2001 Oct; 7(10):3151-5. PubMed ID: 11595709
[TBL] [Abstract][Full Text] [Related]
4. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
Yahata H; Kobayashi H; Kamura T; Amada S; Hirakawa T; Kohno K; Kuwano M; Nakano H
J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
[TBL] [Abstract][Full Text] [Related]
5. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
6. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
[TBL] [Abstract][Full Text] [Related]
7. YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity.
Giménez-Bonafé P; Fedoruk MN; Whitmore TG; Akbari M; Ralph JL; Ettinger S; Gleave ME; Nelson CC
Prostate; 2004 May; 59(3):337-49. PubMed ID: 15042610
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer.
Huang X; Ushijima K; Komai K; Takemoto Y; Motoshima S; Kamura T; Kohno K
Gynecol Oncol; 2004 May; 93(2):287-91. PubMed ID: 15099935
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D.
Asakuno K; Kohno K; Uchiumi T; Kubo T; Sato S; Isono M; Kuwano M
Biochem Biophys Res Commun; 1994 Mar; 199(3):1428-35. PubMed ID: 7908518
[TBL] [Abstract][Full Text] [Related]
10. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.
Ise T; Nagatani G; Imamura T; Kato K; Takano H; Nomoto M; Izumi H; Ohmori H; Okamoto T; Ohga T; Uchiumi T; Kuwano M; Kohno K
Cancer Res; 1999 Jan; 59(2):342-6. PubMed ID: 9927044
[TBL] [Abstract][Full Text] [Related]
13. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
14. Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer.
Huang J; Tan PH; Li KB; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2005 Mar; 26(3):607-13. PubMed ID: 15703814
[TBL] [Abstract][Full Text] [Related]
15. Nuclear expression of YB-1 in diffuse large B-cell lymphoma: correlation with disease activity and patient outcome.
Xu W; Zhou L; Qin R; Tang H; Shen H
Eur J Haematol; 2009 Oct; 83(4):313-9. PubMed ID: 19500133
[TBL] [Abstract][Full Text] [Related]
16. The pleiotropic functions of the Y-box-binding protein, YB-1.
Kohno K; Izumi H; Uchiumi T; Ashizuka M; Kuwano M
Bioessays; 2003 Jul; 25(7):691-8. PubMed ID: 12815724
[TBL] [Abstract][Full Text] [Related]
17. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.
Yasen M; Kajino K; Kano S; Tobita H; Yamamoto J; Uchiumi T; Kon S; Maeda M; Obulhasim G; Arii S; Hino O
Clin Cancer Res; 2005 Oct; 11(20):7354-61. PubMed ID: 16243807
[TBL] [Abstract][Full Text] [Related]
18. Expression of survivin and correlation with PCNA in osteosarcoma.
Wang W; Luo H; Wang A
J Surg Oncol; 2006 Jun; 93(7):578-84. PubMed ID: 16705726
[TBL] [Abstract][Full Text] [Related]
19. A role for Y-box proteins in cell proliferation.
Ladomery M; Sommerville J
Bioessays; 1995 Jan; 17(1):9-11. PubMed ID: 7702598
[TBL] [Abstract][Full Text] [Related]
20. Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.
Okamoto T; Izumi H; Imamura T; Takano H; Ise T; Uchiumi T; Kuwano M; Kohno K
Oncogene; 2000 Dec; 19(54):6194-202. PubMed ID: 11175333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
